BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2088649)

  • 1. Penicillamine in systemic sclerosis: a reappraisal.
    Sattar MA; Guindi RT; Sugathan TN
    Clin Rheumatol; 1990 Dec; 9(4):517-22. PubMed ID: 2088649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on the solubility of skin collagen in scleroderma and the effect of D-penicillamine].
    Zimmermann BK; Balda BR
    Arch Dermatol Forsch; 1972; 243(4):357-63. PubMed ID: 5079382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Systemic sclerosis].
    Gustafsson R
    Nord Med; 1994; 109(8-9):236-7. PubMed ID: 7937033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigations on the mode of action of D-penicillamine (Metalcaptase) in sclerodermia].
    Daróczy J; Gyöngyvér S
    Munch Med Wochenschr; 1973 Aug; 115(31):1363-7. PubMed ID: 4741080
    [No Abstract]   [Full Text] [Related]  

  • 5. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
    Davis P; Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
    [No Abstract]   [Full Text] [Related]  

  • 6. D-penicillamine in the treatment of localized scleroderma.
    Falanga V; Medsger TA
    Arch Dermatol; 1990 May; 126(5):609-12. PubMed ID: 2334179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine [see comment].
    Jimenez SA; Sigal SH
    J Rheumatol; 1991 Oct; 18(10):1496-503. PubMed ID: 1765974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of scleroderma.
    Adnan ZA
    Acta Med Indones; 2008 Apr; 40(2):109-12. PubMed ID: 18560030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
    Bluestone R; Grahame R; Holloway V; Holt PJ
    Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of scleroderma with PUVA therapy.
    Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
    J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillamine therapy in systemic sclerosis.
    Jayson MI; Lovell C; Black CM; Wilson RS
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive systemic sclerosis and penicillamine.
    Rodnan GP
    J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and maturation of skin collagen in scleroderma, and effect of D-penicillamine.
    Herbert CM; Lindberg KA; Jayson MI; Bailey AJ
    Lancet; 1974 Feb; 1(7850):187-92. PubMed ID: 4129876
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials for the treatment of systemic sclerosis/scleroderma.
    Varga J; Ponor I
    Curr Rheumatol Rep; 1999 Oct; 1(1):13-4. PubMed ID: 11123008
    [No Abstract]   [Full Text] [Related]  

  • 16. D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis.
    Steen VD; Medsger TA; Rodnan GP
    Ann Intern Med; 1982 Nov; 97(5):652-9. PubMed ID: 7137731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-penicillamine in systemic sclerosis? Yes!
    Medsger TA; Lucas M; Wildy KS; Baker C
    Scand J Rheumatol; 2001; 30(4):192-4. PubMed ID: 11578011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term evaluation of penicillamine or cyclofenil in systemic sclerosis. Results from a two-year randomized study.
    Akesson A; Blom-Bülow B; Scheja A; Wollmer P; Valind S; Wollheim FA
    Scand J Rheumatol; 1992; 21(5):238-44. PubMed ID: 1439632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of D-penicillamine on pulmonary findings in systemic sclerosis.
    Steen VD; Owens GR; Redmond C; Rodnan GP; Medsger TA
    Arthritis Rheum; 1985 Aug; 28(8):882-8. PubMed ID: 4026885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.